3 unknown, 2 not yet recruiting, 1 active not recruiting, 1 completed. 3 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Not yet recruiting 1, Unknown 1 |
| Phase 3 | 3 | Unknown 2, Not yet recruiting 1 |
Follow Meng Qiu: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SHR-3821 in Advanced Colorectal Cancer: an Exploratory Study SHR-3821 and fruquintinib - Colorectal Cancer | Phase 2 | Not yet recruiting | Meng Qiu | 12 | 2026-04-27 | 2026-04-07 |
| First-line Treatment of MCapOX + Cetuximab Vs. MFOLFOX6 + Cetuximab for RAS/BRAF Wild-type, MSS, Unresectable Left-Sided MCRC: a Multicenter, Randomized, Controlled, Phase III Study mCapOX plus Cetuximab, mFOLFOX6 plus Cetuximab - Colorectal Cancer (CRC), Capecitabine | Phase 3 | Not yet recruiting | Meng Qiu | 452 | 2024-09-26 | 2024-09-27 |
| Fruquintinib Plus S-1 and Raltitrexed (RSF) for MCRC Fruquintinib, S-1, raltitrexed - Fruquintinib, S-1 | Phase 2 | Unknown | Meng Qiu | 66 | 2023-02-20 | 2025-01-22 |
| FOLFOXIRI-based HAIC Combined With Fuquintinib as Late-line Treatment in Patients With CRLM：A Phase 2 Single-Arm Clinical Trial FOLFOXIRI-based HAIC+Fuquinitinib - Colorectal Neoplasms | Phase 2 | Completed | Meng Qiu | 44 | 2023-01-12 | 2026-04-30 |
| The Efficacy and Safety of a Compound Glutamine Capsule in the Primary Prevention of Chemotherapy-induced Mucositis a compound glutamine capsule/a compound glutamine capsule simulated placebo - Mucositis, Chemotherapeutic Toxicity | Phase 3 | Unknown | Meng Qiu | 108 | 2021-06-30 | 2021-10-25 |
| The Efficacy and Safety of a Compound Glutamine Capsule in the Prevention of Chemotherapy-induced Mucositis a compound glutamine capsule, a compound glutamine capsule simulated placebo - Mucositis, Chemotherapeutic Toxicity | Phase 3 | Unknown | Meng Qiu | 90 | 2021-06-30 | 2021-10-15 |
| Correlation and Heterogeneity of the Immune Microenvironment and Histopathological Growth Patterns in Resectable Colorectal Cancer Liver Metastases Formalin-fixed, paraffin-embedded (FFPE) sections of colorectal cancer liver metastases were stained with hematoxylin and eosin (H&E) and Multiplex immunohistochemistry (mIHC) staining. - Colorectal Neoplasms | Active not recruiting | Meng Qiu | 64 | 2018-01-01 | 2026-05-04 |
Colorectal Neoplasms (4) · Mucositis (2)
HMPL-013 (2) · Cetuximab (1) · Eosine Yellowish-(YS) (1) · Hematoxylin (1) · S 1 (combination) (1) · Staining and Labeling (1) · Tegafur (1) · gimeracil (1) · potassium oxonate (1) · raltitrexed (1)
China (6)